Bio Solution Co.,Ltd. (KOSDAQ:086820)

South Korea flag South Korea · Delayed Price · Currency is KRW
9,570.00
+760.00 (8.63%)
At close: Aug 28, 2025
8.63%
Market Cap228.64B
Revenue (ttm)8.27B
Net Income (ttm)-1.28B
Shares Out23.89M
EPS (ttm)-53.69
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume235,738
Average Volume70,715
Open8,740.00
Previous Close8,810.00
Day's Range8,690.00 - 9,730.00
52-Week Range4,136.67 - 13,200.00
Beta0.66
RSI67.87
Earnings Daten/a

About Bio Solution

Bio Solution Co.,Ltd. develops, manufactures, and sells cell therapy products worldwide. The company offers CartiLife, an autologous chondrocyte cell-based therapy for the restoration of symptomatic and structural complications caused by articular cartilage defects; KeraHeal-Allo, a thermosensitive hydrogel-type allogenic keratinocyte cell-therapy product to promote re-epithelialization of deep 2nd-degree burn wounds; and KeraHeal, an autologous spray-type keratinocyte cell-based therapy for skin wounds. It also provides reconstructed human mic... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Employees 71
Stock Exchange KOSDAQ
Ticker Symbol 086820
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.